Participant eaten grapefruit or grapefruit solutions within 3 days ahead of the primary dose of study drug. - "Our study disclosed the critical part of the KLF16/MYC regulatory axis in modulating tumor expansion and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, including OTX015 or ABBV-744, with DDP or https://georges998epa1.blogozz.com/profile